Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-16

Clinical Trial Update: Study to Assess the Efficacy and Safety of Tizaspray® Versus Sirdalud®, in Patients With Acute Low Back Pain [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing Tizaspray with Sirdalud in acute low back pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sirdalud (tizanidine)
  • Tizaspray

Snippet

Sponsor: MDM S.p.A. | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED